Growth Metrics

Uxin (UXIN) EBIAT (2018 - 2025)

Historic EBIAT for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to -$60.7 billion.

  • Uxin's EBIAT fell 258.24% to -$60.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.7 billion, marking a year-over-year increase of 6992.12%. This contributed to the annual value of -$46.9 million for FY2024, which is N/A changed from last year.
  • Per Uxin's latest filing, its EBIAT stood at -$60.7 billion for Q3 2025, which was down 258.24% from -$9.4 million recorded in Q2 2025.
  • Uxin's 5-year EBIAT high stood at $160.0 million for Q2 2022, and its period low was -$266.1 billion during Q3 2021.
  • Moreover, its 5-year median value for EBIAT was -$14.2 million (2023), whereas its average is -$42.8 billion.
  • In the last 5 years, Uxin's EBIAT soared by 33121.17% in 2022 and then crashed by 75557390076.62% in 2024.
  • Quarter analysis of 5 years shows Uxin's EBIAT stood at -$72.8 billion in 2021, then skyrocketed by 100.0% to -$100840.0 in 2022, then increased by 22.55% to -$78096.0 in 2023, then tumbled by 15747.16% to -$12.4 million in 2024, then crashed by 490341.18% to -$60.7 billion in 2025.
  • Its EBIAT stands at -$60.7 billion for Q3 2025, versus -$9.4 million for Q2 2025 and -$7.1 million for Q1 2025.